Top Markets
Coin of the day
Theranexus Société Anonyme Theranexus Société Anonyme

Theranexus Société Anonyme

ALTHX
Clasificación en acciones #15061
Theranexus société anonyme, a biopharmaceutical company, develops drug... Theranexus société anonyme, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders. The company's lead drug candidate is THN102, which is in Phase II clinical trial to treat sleep/wake disorders. It also develops THN201 for the treatment of neurocognitive disorders linked to Alzheimer's disease; and THN101 to treat neuropathic pain. The company was founded in 2013 and is based in Lyon, France.
Precio por acción
$4.66
Capitalización bursátil
$43.92M
Cambio (1 día)
-0.63%
Cambio (1 año)
338.04%
País
FR
Comercio Theranexus Société Anonyme (ALTHX)

Categoría

Ratio P/S de Theranexus Société Anonyme (ALTHX)
Ratio P/S al July 2026 TTM: 38.28
Según los informes financieros más recientes y el precio de las acciones de Theranexus Société Anonyme, el ratio P/S actual (TTM) es 38.28. Al final de 2023, el ratio P/S era 29.32.
Historial del ratio P/S de Theranexus Société Anonyme desde 2015 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
2026 (TTM) 38.28 1,672.34%
2024 2.16 -92.63%
2023 29.32 30.81%
2022 22.42 -99.94%
2021 40.48K 15,636.51%
2020 257.27 1,228.70%
2019 19.36 -96.16%
2018 503.88 58.16%
2017 318.60 108.08%
2016 153.11 519.84%
2015 24.70 0.00%
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
4.26 -88.86%
DK
10.29 -73.13%
US
4.31 -88.75%
US
6.44 -83.17%
BE
16.96 -55.70%
NL